Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1969 1
1973 1
1979 1
1985 1
2005 1
2006 2
2007 1
2008 3
2009 4
2010 3
2011 7
2012 7
2013 7
2014 8
2015 13
2016 4
2017 1
2018 6
2019 11
2020 6
2021 8
2022 9
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells.
Saleiro D, Kosciuczuk EM, Fischietti M, Perez RE, Yang GS, Eckerdt F, Beauchamp EM, Hou Y, Wang Q, Weinberg RS, Fish EN, Yue F, Hoffman R, Platanias LC. Saleiro D, et al. Among authors: beauchamp em. Cancer Res Commun. 2023 May 31;3(5):943-951. doi: 10.1158/2767-9764.CRC-23-0010. eCollection 2023 May. Cancer Res Commun. 2023. PMID: 37377894 Free PMC article.
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression.
Fischietti M, Eckerdt F, Perez RE, Guillen Magaña JN, Mazewski C, Ho S, Gonzalez C, Streich LD, Beauchamp EM, Heimberger AB, Baran AH, Yue F, James CD, Platanias LC. Fischietti M, et al. Among authors: beauchamp em. Cancer Res Commun. 2022 Sep;2(9):966-978. doi: 10.1158/2767-9764.crc-22-0192. Epub 2022 Sep 13. Cancer Res Commun. 2022. PMID: 36382088 Free PMC article.
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.
Saleiro D, Wen JQ, Kosciuczuk EM, Eckerdt F, Beauchamp EM, Oku CV, Blyth GT, Fischietti M, Ilut L, Colamonici M, Palivos W, Atsaves PA, Tan D, Kocherginsky M, Weinberg RS, Fish EN, Crispino JD, Hoffman R, Platanias LC. Saleiro D, et al. Among authors: beauchamp em. Nat Commun. 2022 Apr 1;13(1):1750. doi: 10.1038/s41467-022-29381-7. Nat Commun. 2022. PMID: 35365653 Free PMC article.
Targeting N-myristoylation for therapy of B-cell lymphomas.
Beauchamp E, Yap MC, Iyer A, Perinpanayagam MA, Gamma JM, Vincent KM, Lakshmanan M, Raju A, Tergaonkar V, Tan SY, Lim ST, Dong WF, Postovit LM, Read KD, Gray DW, Wyatt PG, Mackey JR, Berthiaume LG. Beauchamp E, et al. Nat Commun. 2020 Oct 22;11(1):5348. doi: 10.1038/s41467-020-18998-1. Nat Commun. 2020. PMID: 33093447 Free PMC article.
Inhibitory effects of Tomivosertib in acute myeloid leukemia.
Suarez M, Blyth GT, Mina AA, Kosciuczuk EM, Dolniak B, Dinner S, Altman JK, Eklund EA, Saleiro D, Beauchamp EM, Platanias LC. Suarez M, et al. Among authors: beauchamp em. Oncotarget. 2021 May 11;12(10):955-966. doi: 10.18632/oncotarget.27952. eCollection 2021 May 11. Oncotarget. 2021. PMID: 34012509 Free PMC article.
97 results